UBS Group AG - SECOND SIGHT MED PRODS INC ownership

Back to all holdings Add to watchlist

SECOND SIGHT MED PRODS INC's ticker is EYESW and the CUSIP is 81362J126. A total of 5 filers reported holding SECOND SIGHT MED PRODS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
UBS Group AG ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q2 2022$1,000
-50.0%
4,562
+54.5%
0.00%–
Q3 2021$2,000–2,952
+19580.0%
0.00%–
Q2 2021$0–15
-99.2%
0.00%–
Q4 2020$0–1,776–0.00%–
 Download
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q2 2022
NameSharesValueWeighting ↓
UBS Group AG 4,562$1,0000.00%
OSAIC HOLDINGS, INC. 45$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 31,325$8,0000.00%
Sigma Planning Corp 19,056$5,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders